FilingReader Intelligence

J.B. Chemicals approved for US drug, acquired by Torrent

June 30, 2025 at 07:05 AM UTCBy FilingReader AI

** J.B. Chemicals & Pharmaceuticals [BSE: JBCHEPHARM] has announced US FDA approval for its Abbreviated New Drug Application (ANDA) for Amitriptyline Hydrochloride Tablets USP (10mg, 25mg, 50mg, 75mg, 100mg, and 150mg), used for treating depression. The approval coincides with a share purchase agreement with Tau Investment Holdings Pte. Ltd., where Torrent Pharmaceuticals Limited will acquire 74,481,519 equity shares (46.39%) for a total consideration of INR119,17,04,30,400.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when J.B. Chemicals & Pharmaceuticals publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →